Terms: = Liver cancer AND CTCF, P49711, 10664, ENSG00000102974
36 results:
1. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors.
Llinàs-Arias P; Ensenyat-Mendez M; Íñiguez-Muñoz S; Orozco JIJ; Valdez B; Salomon MP; Matsuba C; Solivellas-Pieras M; Bedoya-López AF; Sesé B; Mezger A; Ormestad M; Unzueta F; Strand SH; Boiko AD; Hwang ES; Cortés J; DiNome ML; Esteller M; Lupien M; Marzese DM
Mol Cancer; 2023 Nov; 22(1):190. PubMed ID: 38017545
[TBL] [Abstract] [Full Text] [Related]
2. Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression.
Ye B; Yu M; Yue M; Yin M; Zhang C; Wang Q; Ding X; Shen W; Zhao Z
Sci Rep; 2023 Jul; 13(1):10946. PubMed ID: 37414929
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Mutation Profiling of Colorectal cancer Patients With Lung or liver Metastasis by Targeted Next-Generation Sequencing.
Hu CT; Wang JL; Hou T; Yan ZW; Zu LD; Fu GH; Shen WW
Technol Cancer Res Treat; 2023; 22():15330338231185285. PubMed ID: 37394872
[TBL] [Abstract] [Full Text] [Related]
4. Essential role of MESP1-RING1A complex in cardiac differentiation.
Liang Q; Wang S; Zhou X; Li Y; Xing S; Sha Y; Yang F; Huang W; Liu N; Li Z; Chen Y; Xu Y; Zhu P; Lan F; Sun N
Dev Cell; 2022 Nov; 57(22):2533-2549.e7. PubMed ID: 36413948
[TBL] [Abstract] [Full Text] [Related]
5. The function of brother of the regulator of imprinted sites in cancer development.
Zhou S; Li L; Zhang M; Qin Y; Li B
Cancer Gene Ther; 2023 Feb; 30(2):236-244. PubMed ID: 36376421
[TBL] [Abstract] [Full Text] [Related]
6. Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci.
Ying Y; Wang M; Chen Y; Li M; Ma C; Zhang J; Huang X; Jia M; Zeng J; Wang Y; Li L; Wang X; Tao Q; Shu XS
Proc Natl Acad Sci U S A; 2022 May; 119(22):e2120633119. PubMed ID: 35605119
[TBL] [Abstract] [Full Text] [Related]
7. Hepatocellular carcinoma risk variant modulates lncRNA HLA-DQB1-AS1 expression via a long-range enhancer-promoter interaction.
Wang H; Yang B; Cai X; Cheng X; Shen N; Liu L; Li J; Wang Y; He H; Ying P; Li B; Lu Z; Yang N; Wang X; Zhang F; Li Y; Wang W; Ning C; Zhu Y; Chang J; Miao X; Tian J; Zhong R
Carcinogenesis; 2021 Nov; 42(11):1347-1356. PubMed ID: 34665859
[TBL] [Abstract] [Full Text] [Related]
8. Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma.
Zhang R; Mo WJ; Huang LS; Chen JT; Wu WZ; He WY; Feng ZB
Bioengineered; 2021 Dec; 12(1):855-874. PubMed ID: 33641617
[TBL] [Abstract] [Full Text] [Related]
9. [3D organization profiling of human hepatocellular carcinoma cell line PLC/PRF/5 in comparison with normal human liver cell line L02 by in situ Hi-C].
Hu H; Chai X; Wang L; Cai J; Lan F
Sheng Wu Gong Cheng Xue Bao; 2021 Jan; 37(1):331-341. PubMed ID: 33501813
[TBL] [Abstract] [Full Text] [Related]
10. ctcf-induced upregulation of LINC01207 promotes gastric cancer progression via miR-1301-3p/PODXL axis.
Yu L; Gao Y; Ji B; Feng Z; Li T; Luan W
Dig Liver Dis; 2021 Apr; 53(4):486-495. PubMed ID: 33495099
[TBL] [Abstract] [Full Text] [Related]
11. ctcf and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong KM; Song J; Wong YH
Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
[TBL] [Abstract] [Full Text] [Related]
12. The CCCTC-binding factor ctcf represses hepatitis B virus enhancer I and regulates viral transcription.
D'Arienzo V; Ferguson J; Giraud G; Chapus F; Harris JM; Wing PAC; Claydon A; Begum S; Zhuang X; Balfe P; Testoni B; McKeating JA; Parish JL
Cell Microbiol; 2021 Feb; 23(2):e13274. PubMed ID: 33006186
[TBL] [Abstract] [Full Text] [Related]
13. Knockdown of ctcf reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma.
Wei L; Liu Q; Huang Y; Liu Z; Zhao R; Li B; Zhang J; Sun C; Gao B; Ding X; Yu X; He J; Sun A; Qin Y
Int J Biochem Cell Biol; 2020 Mar; 120():105685. PubMed ID: 31917284
[TBL] [Abstract] [Full Text] [Related]
14. DNA Methylation Activates TP73 Expression in Hepatocellular Carcinoma and Gastrointestinal cancer.
Yao Z; Di Poto C; Mavodza G; Oliver E; Ressom HW; Sherif ZA
Sci Rep; 2019 Dec; 9(1):19367. PubMed ID: 31852961
[TBL] [Abstract] [Full Text] [Related]
15. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
16. COUP-TFII is a modulator of cell-type-specific genetic programs based on genomic localization maps.
Erdős E; Bálint BL
J Biotechnol; 2019 Aug; 301():11-17. PubMed ID: 31158411
[TBL] [Abstract] [Full Text] [Related]
17. The effect of ctcf binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma.
Gong W; Liu Y; Qu H; Liu A; Sun P; Wang X
Biochem Biophys Res Commun; 2019 Mar; 510(4):530-538. PubMed ID: 30738580
[TBL] [Abstract] [Full Text] [Related]
18. DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.
Oshima G; Poli EC; Bolt MJ; Chlenski A; Forde M; Jutzy JMS; Biyani N; Posner MC; Pitroda SP; Weichselbaum RR; Khodarev NN
Cancer Res; 2019 Feb; 79(3):650-662. PubMed ID: 30538122
[TBL] [Abstract] [Full Text] [Related]
19. ctcf maintains regulatory homeostasis of cancer pathways.
Aitken SJ; Ibarra-Soria X; Kentepozidou E; Flicek P; Feig C; Marioni JC; Odom DT
Genome Biol; 2018 Aug; 19(1):106. PubMed ID: 30086769
[TBL] [Abstract] [Full Text] [Related]
20. miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 1 Subfamily A Member 2 and Family 2 Subfamily E Member 1 Expression.
Chowdhary V; Teng KY; Thakral S; Zhang B; Lin CH; Wani N; Bruschweiler-Li L; Zhang X; James L; Yang D; Junge N; Brüschweiler R; Lee WM; Ghoshal K
Am J Pathol; 2017 Dec; 187(12):2758-2774. PubMed ID: 28963035
[TBL] [Abstract] [Full Text] [Related]
[Next]
